Why suggestion to have CSR account in government hospitals not followed: HC asks Centre, Delhi government

PTI Mar 14, 2019

The Delhi High Court on March 13 asked the Centre and the AAP government why they have not followed its suggestion to have a separate account in hospitals run by them to receive donations from charitable entities or companies under corporate social responsibility (CSR).

A bench of Chief Justice Rajendra Menon and Justice A J Bhambani issued notice to the Ministry of Health and the Delhi government's Health Department seeking their response on the issue which the court has taken up as a PIL on its own. The court initiated the PIL after receiving a letter from an NGO, Heart Care Foundation of India, which claimed that neither the central government nor the Delhi government had followed the various suggestions, including having a separate CSR account, given by the high court in a 2014 judgement.

CSR is an initiative under which companies can contribute to welfare of society either financially or through their products and services free of cost. In its 2014 judgement, the high court had suggested that all government hospitals, run by the Centre and the state, could have a separate CSR or charitable entity account wherein donations can be received. The donations could be subject to an audit.

Apart from that it had also suggested having a designated officer in all hospitals to whom applications for assistance can be made by patients in need. "Government hospitals could put up a list on the state department of Health website of the drugs, implants and devices they require for economically weaker section (EWS) or below poverty line (BPL) patients. This way people would donate as per the need of each hospital. This could be revised on a monthly basis.

"The state government may put up a list of drugs, implants and devices which are excluded from its budget for which donations would be welcome," were the other suggestions given by the high court.

The suggestions by the court had come in its judgement directing the Delhi government to provide enzyme replacement therapy (ERT) free of cost at AIIMS to a poor minor boy, who was suffering from a rare genetic disorder for which ERT was the only treatment, whenever he needs it. The NGO in its letter to the high court has contended that more than four years after the judgement, none of the suggestions have been followed till date.

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
Topic: General medicine, Family medicine
Which parameter is NOT affected by using olmesartan-based, single-pill, dual-combination (+ amlodipine/azelnidipine or HCTZ) therapy vs olmesartan monotherapy for 8 weeks in adults with hypertension?

Sign up with M3 India to try daily quizzes and take part in competitions

Try M3 India / Log In
Doctor taking survey

Why join our Market Research Panel?

  • 10K+ Doctors participated in 40+ Indian and Global studies in 2018
  • Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor
This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen